ROCO
1565
Market cap154mUSD
Oct 08, Last price
97.50TWD
1D
0.21%
1Q
0.52%
Jan 2017
-84.15%
IPO
-81.94%
Name
St.Shine Optical Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
St.Shine Optical Co.,Ltd., headquartered in New Taipei City, Taiwan, is a prominent entity involved in the manufacturing, distribution, and sales of ophthalmic products, including contact lenses and optical lenses. The company's reach extends across diverse global markets, encompassing Asia, Europe, America, and Taiwan. Its extensive product portfolio features a variety of soft contact lenses, such as daily disposable, frequent replacement, and colored options, alongside advanced silicone hydrogel and traditional cast-molded types. These offerings are primarily marketed under the Ticon brand. The core purpose of their products is to rectify common vision impairments, specifically addressing refractive errors like myopia (nearsightedness), hyperopia (farsightedness), and astigmatism. Established in 1986, the firm initially operated under the name First Optical Co., Ltd., adopting its current corporate identity, St.Shine Optical Co.,Ltd., in the same year.
Key people
Chairman of the Board, Deputy General Manager-Greater China Business Department · since 2006
Eris Lin
Finance Manager, Corporate Governance Officer · since 2022
Johnson Chou
Chief Executive Officer, General Manager, Director · since 2001
Yu Hao Chen
Director · since 2021
Ying-Chieh Chu
Director · since 2009
Peter Ho
Director · since 2021
Audrey Tseng
Director · since 2024
Independent Director · since 2021
Chang-Chou Li
Independent Director · since 2021
I-Yen Lu
Independent Director · since 2021
Valuation
Title TWD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||